Les cellules dendritiques jouent un rôle primordial dans le système immunitaire. En effet, ces cellules sont à l'interface entre l'immunité innée et adaptative par leur capacité de reconnaissance, d'internalisation et de dégradation de pathogènes afin de présenter des antigènes aux lymphocytes. La capacité de reconnaissance est engendrée par l'expression de différents récepteurs à la surface de ces cellules. Parmi ces récepteurs, deux grandes familles permettent la reconnaissance d'un large panel de différents pathogènes, comme les TLRs (« Toll-Like Receptors) et les lectines de type-C. Ces récepteurs sont utilisés comme marqueurs des différents sous-types de cellules dendritiques. Par exemple, parmi les lectines de type-C, DC-SIGN est majoritairement exprimée dans les cellules dendritiques dermiques alors que la Langérine est, quand à elle, fortement exprimée par les cellules dendritiques épidermiques, les cellules de Langerhans. Ces deux sous-types de cellules dendritiques divergent par leur réponse à l'infection par le VIH (« virus d'immunodéficience humain »). En effet, le virus utilise DC-SIGN pour détourner le rôle de ces cellules afin d'infecter les lymphocytes T alors que la reconnaissance du VIH par la Langérine, dans les cellules de Langerhans, conduit à la clairance de virus par son internalisation dans le granule de Birbeck. Cet organite est spécifique des cellules de Langerhans et nécessite l'expression de la Langérine. Ce travail de thèse s'est donc focalisé sur la caractérisation structurale et fonctionnelle de la Langérine. Il a permis de mettre en évidence l'importance de la structure tertiaire du domaine CRD et de la structure quaternaire de la protéine pour la formation et la bonne structuration du granule de Birbeck. Ensuite, l'étude fonctionnelle de cette lectine, notamment par résonance plasmonique de surface, nous a conduit à identifier une nouvelle spécificité de reconnaissance de la Langérine pour les glycosaminoglycanes dans un site d'interaction différent du site canonique. Enfin, nous avons caractérisé une spécificité de reconnaissance du site canonique pour les monosaccharides sulfatés de type glucosamine en utilisant la résonance plasmonique de surface et la cristallographie. / Dendritic cells play a crucial role in the immune system. Indeed, these cells are at the interface between innate and acquired immunity by their capacities of recognition, internalisation and pathogen degradation to present antigens to T lymphocytes. The recognition capacity is generated by the expression of diverse receptors onto the cell surface. Among these receptors, two large families allow the recognition of a large panel of different pathogens, as TLRs (“Toll-Like Receptor) and C-type lectins. These receptors are used as markers of different dendritic cells subtypes. For example, and among the C-type lectins, DC-SIGN is mainly expressed onto dermic dendritic cells contrary to langerin, which is highly expressed onto epidermic dendritic cells, called Langerhans cells. These two subtypes of dendritic cells differ in their response of HIV infection. Indeed, the virus recognition by DC-SIGN enables hijacking the dendritic cell to infect T lymphocyte contrary to langerin recognition, in Langerhans cells, which allows the clearance of the virus by its internalisation into Birbeck granules. This organite is specific of Langerhans cells and requires langerin expression. This work is focused on structural and functional characterisation of langerin. It highlights the importance of the CRD tertiary structure and the quaternary structure of the protein for the formation and the structure of Birbeck granules. Then, functional study by surface plasmon resonance enabled us to identify a new binding site of langerin for glycosaminoglycans. Finally, we have characterised a recognition specificity of langerin for sulphated monosaccharide of glucosamine type using surface plasmon resonance and crystallography.

Introdução: Rosácea é uma doença inflamatória cutânea crônica relativamente comum, com incidência que varia de 2 a 10%. Caracteriza-se pelo surgimento de pápulas e pápulo-pustulas, eritema e telangiectasias precedidas por episódios de flushing. Apesar de não ser doença que comprometa o estado geral dos doentes, por ter acometimento preferencial da face, representa problema estético acentuado que interfere na socialização e qualidade de vida dos doentes. A etiologia da rosácea permanece incerta. A participação da imunidade inata tem sido implicada recentemente. Objetivo: Este estudo avaliou o envolvimento da imunidade inata na patogenia da rosácea através de pesquisa de células de Langerhans, células plasmocitóides (PDC), receptores \"toll-like\" (TLR) e expressão da forma induzida da enzima óxido nítrico sintase (iNOS) em biopsias de pele de pacientes com diagnóstico de rosácea. Métodos: Biopsias de 28 pacientes com diagnóstico clínico e histopatológico de Rosácea foram classificadas de acordo com características histopatológicas em Rosácea Granulomatosa (RG) (n = 10) e Rosácea Não Granulomatosa (RNG) (n = 18), e submetidas à técnica imunoistoquímica para demonstração de células de Langerhans (anticorpo anti-CD1a) (n = 26), PCD (anticorpo anti- CD123) (n = 24) e expressão dos receptores toll-like 2 e 4, bem como da forma induzida da óxido nítrico sintase (iNOS) (n = 28). Todos foram comparados com controles de pele normal (n = 15). Resultados: A população de células de Langerhans epidérmicas foi menor no grupo rosácea. Foram encontradas PDC dérmicas isoladas ou agrupadas no grupo rosácea, representando um novo dado no estudo da sua etiopatogenia. A expressão de TLR 2, TLR 4 e iNOS foi maior no grupo rosácea do que no grupo controle, estando distribuída com forte predominância na epiderme e anexos. Não houve diferença dos achados entre os grupos RG e RNG. Conclusão: Demonstrou-se, pela primeira vez, a presença de PDC nas lesões de rosácea. Juntamente com os outros marcadores estudados, os resultados apresentados confirmam a participação da imunidade inata na patogênese da rosácea através de mecanismos interdependentes e associados / Introduction: Rosacea is a common, chronic inflammatory condition with a reported prevalence between 2 and 10%. The disease has a variety of clinical manifestations that include flushing, persistent erythema, papules, pustules and telangiectasia. Because the facial skin is the predominant site of involvement, many patients sense that rosacea alters their social interactions affecting quality of life. The etiology of rosacea remains unknown. Recent studies have suggested that aberrant innate immunity is central to this disease. Objective: The aim of the present study was to examine the presence of Langerhans cells, plasmacytoid dentritic cells (PDC), and the expression of toll-like receptors (TLR) and inducible oxide nitric synthase (iNOS) in skin of patients with rosacea, in order to highlight the participation of innate immunity in the pathogenesis of this disease. Methods: 28 biopsy specimens were taken from patients with clinical and histopathological findings of rosacea. The samples were classified as Granulomatous rosacea (GR) (n= 10) or Non-Granulomatous rosacea (NGR) (n =18) according to histopathological features. Immunohistochemical demonstration of Langerhans cells (anti-CD1a antibody) (n = 24), PDC (anti-CD 123 antibody) (n = 26), TLR 2, TLR 4 and iNOS (n = 28) was performed in skin samples. The results were compared to normal skin control group (n = 15). Results: The number of Langerhans cells was lower in rosacea group than in control group. PDC were found in skin samples of rosacea as isolated cells and forming small clusters which represents a new contribution to the researches of its etiology. Expression of TLR2, TLR4 and iNOS was higher in rosacea samples than in normal skin controls, predominatly located in epidermal and adnexal structures. The comparison between GR and NGR groups did not show significant statistical difference. Conclusion: This research demonstrates, for the first time, the presence of PDC in lesions of rosacea, which together with the other results of this study, ratifies the existence of an altered innate immunity in pathogenesis of rosacea

Atualmente existem diversas opções terapêuticas para o tratamento do fotoenvelhecimento cutâneo.Uma das formas de tratamento muito utilizada é a fototerapia com laser. Com o desenvolvimento da tecnologia em lasers surgiu um novo conceito de tratamento da pele envelhecida, a fototermólise fracionada microablativa. Essa tecnologia fracionada visa combinar os efeitos visíveis de uma terapia ablativa com o conforto e segurança dos métodos não ablativos. Antes de atingir a pele o laser passa por uma lente óptica especial que o divide em microrraios. Tal procedimento produz colunas de lesões térmicas microscópicas que penetram na epiderme e derme, sem danificar o tecido circunvizinho. A grande vantagem de ser fracionado é que a pele íntegra ao redor de cada coluna funciona como um reservatório de células potentes para a rápida cicatrização e regeneração da pele, culminando com a produção de colágeno e resultando em uma pele mais jovial, sem o inconveniente de um longo período de recuperação pós-tratamento. 20 pacientes foram selecionadas para o tratamento das rítides periorais com uma sessão de laser Erbium-YAG de 2940nm, fracionado. Após 28 dias do procedimento observou-se melhora na textura da pele, clareamento de manchas e atenuação de rugas finas periorais. Foi realizado um estudo comparativo da quantificação das células de Langerhans e receptores toll-like ( TLRs ) 2, 3 e 9 na epiderme, antes e após 3, 7, 14 e 28 dias do tratamento e da quantificação das fibras de colágeno na derme superior, antes e após 28 dias do laser. Houve diferenças estatisticamente significativas entre as medianas dos valores de CD1a (p = 0,0085), TLR 2 (p = 0,0108), TLR 3 (p = 0,0011) e TLR 9 (p = 0,0012) na epiderme pré e pós-tratamento. Foi constatado que a significância se deu entre os valores: antes e após 14 dias para CD1a (diminuição), antes e após 7 dias para TLR 2 (diminuição), antes e após 14 dias para TLR 3 (aumento), antes e após 7 dias para TLR 9 (diminuição). Não se encontraram diferenças estatisticamente significativas entre os valores medianos das fibras colágenas do tipo I (p = 1,0000) e III (p = 0,3125) antes e após 28 dias do tratamento. O protocolo desse estudo mostrou-se bastante seguro, pois apresentou efeitos colaterais transitórios e nenhuma complicação permanente. / There are several treatment options for skin photoaging. One of them widely used nowadays is lasertherapy. The development of lasers technology introduced a new therapeutic concept for aging skin: ablative fractional photothermolysis. This technology combines the visible effects of an ablative therapy with the comfort and safety of nonablative methods. Before reaching the skin the laser passes through a special optical lens that splits it into tiny rays. This procedure produces columns of microscopic thermal injuries that penetrate the epidermis and dermis, without damaging the surrounding tissue. The great advantage of the fractional photothermolysis is that the intact skin around each column acts as a potent reservoir of cells for fast healing and skin regeneration, resulting in collagen production and a youthful skin without the inconvenience of a long period of recovery after treatment. 20 patients were selected for perioral wrinkles treatment with a session of fractional Erbium-YAG 2940nm. After 28 days of the procedure the perioral skin showed improvement in texture, bleaching of sunspots and attenuation of superficial wrinkles. A comparative study was conducted between the expression of Langerhans cells and toll-like receptors 2, 3 and 9 in the epidermis, before and after 3,7,14 and 28 days of treatment and among collagen fibers in the dermis, before and after 28 days of the laser. There were statistically significant differences between the median values of CD1a (p = 0.0085), TLR 2 (p = 0.0108), TLR 3 (p = 0.0011) and TLR 9 (p = 0.0012) in the epidermis pre and post-treatment. The significance occurred between the values: before and after 14 days for CD1a (decrease) before and after 7 days to TLR 2 (decrease) before and after 14 days for TLR 3 (increase) before and after 7 days for TLR 9 (decrease). There were not statistically significant differences between the median values of collagen type I (p = 1.0000) and III (p = 0.3125) before and after 28 days of treatment. The irradiation of skin with fractional Erbium-YAG was safe, as it showed transitory side effects and no permanent complication.

L. (L.) amazonensis (La) e L. (V.) braziliensis (Lb) podem causar um espectro de manifestações clínicas e imunopatológicas no homem, sendo La responsável pela forma anérgica difusa e Lb pela forma mucocutânea da doença, formas polares e de elevada gravidade. Neste sentido, o objetivo do presente estudo foi avaliar os aspectos da resposta imune celular no ponto de inoculação e no linfonodo de drenagem de camundongos BALB/c inoculados no coxim plantar com 106 promastigotas de La e Lb. A evolução da lesão foi avaliada semanalmente sendo que na 4ª e 8ª semana PI biópsias do ponto de inoculação foram coletadas para determinação da densidade de células dendríticas (CD207+ e CD11c+), linfócitos T CD4+ e CD8+ e células iNOS+ por imunoistoquímica, e o linfonodo de drenagem para caracterização de subpopulações de células dendríticas e de linfócitos T CD4 e CD8 por citometria de fluxo. Células de linfonodo de drenagem foram cultivadas, com estímulo homólogo, para quantificação de citocinas (IL-4, IL- 10 e IFN-g) e nitrito nos sobrenadantes. A infecção por La levou à progressão da doença, com aumento do tamanho da lesão e da carga parasitária tanto na pele quanto no linfonodo de drenagem, enquanto que a infecção por Lb mostrou um discreto aumento da lesão entre a 6ª e 7ª semana PI com posterior regressão e redução da carga parasitária na pele e no linfonodo de drenagem. Aumento do número de células dendríticas dérmicas e de Langerhans foi observado na pele de camundongos inoculados com La na 4ª semana PI, juntamente com o aumento no número de células de Langerhans nos linfonodos de drenagem. Resposta imune celular preferencial de células T CD4+ foi observada tanto na pele quanto no linfonodo de camundongos inoculados com La, que mostrou ser predominantemente do tipo Th2 com a produção aumentada de IL-10 e IL-4. Já a infecção por Lb levou ao aumento na expressão de células dendríticas dérmicas e Langerhans na pele dos animais inoculados com Lb somente na 8ª semana PI, assim como aumento do número de células dendríticas dérmicas no linfonodo. A resposta imune celular foi caracterizada por células T CD4+ e CD8+ em pele e linfonodo dos animais infectados com Lb, vinculada a um perfil Th1 com a produção preferencial de IFN-g e altos níveis de NO. Aumento no número de células T regulatórias foi observado na infecção por Lb, que mostrou correlação direta com o número de linfócitos T CD4+ produtores de IL-10. Assim, a infecção por La foi relacionada à suscetibilidade, enquanto que a infecção por Lb foi relacionada à resistência do hospedeiro vertebrado. Estes resultados evidenciam não só o papel do parasita na modulação da resposta imune do hospedeiro como também das células dendríticas à infecção por Leishmania / L. (L.) amazonensis (La) and L. (V.) braziliensis (Lb) are responsible for a spectrum of clinical and immunopathological manifestations in humans, La is able to cause anergic diffuse leishmaniasis and Lb mucocutaneous leishmaniasis, polar forms with high severity. In this way, the aim of the present study was to evaluate aspects of the cellular immune response in the site of infection and in the draining lymph node of BALB/c mice inoculated in the hind footpad with 106 promastigotes of La and Lb. The evolution of the lesion size was evaluated weekly and in the 4th and 8th week PI biopsies from the site of infection were collected to determine the density of dendritic cells (CD207+ and CD11c+), CD4+ and CD8+ T cells and iNOS+ cells by immunohistochemistry, and the draining lymph node to characterize subsets of dendritic cells and CD4+ and CD8+ T cells by flow citometry. The draining lymph nodes cells were cultured with specific antigen to determine the cytokines (IL-4, IL-10 e IFN-g), and the nitric oxide in the supernatants. The infection caused by La led to the progression of disease with increase on lesion size and parasite load in the skin and draining lymph node, while Lb infection showed a discrete increase on the lesion size between 6th and 7th week PI with late regression and reduction in the skin as well as lymph node parasite load. An increase on the number of dermal dendritic and Langerhans cells were observed in the skin of BALB/c mice infected with La at 4th week PI together with an increase of Langerhans cells in the draining lymph node. The preferential CD4+ T cell immune response was observed in skin and lymph node of mice infected with La, which showed to be rather Th2 with an increase on the levels of IL-4 and IL-10. However, Lb infection led an increase of dermal dendritic cells and Langerhans cells in the skin only at 8th week PI, as well as an increase in the dermal dendritic cells in lymph node. The cellular immune response were characterized by CD4+ and CD8+ T cells in the skin and draining lymph node of mice infected with Lb, which was related to a Th1 immune response with production of high levels of IFN-g and nitric oxide. An increase of Regulatory T cells was observed in Lb infection, which showed the positive correlation with the IL-10 producing CD4+ T cells. So, the La infection was related to the susceptibility, while Lb infection was related to the resistance in the vertebrate host. These results emphasize the role of the parasite in the modulation of the host immune response to Leishmania infection

Ma thèse a permis de développer une nouvelle approche pour étudier, par imagerie in vivo, le comportement des cellules présentatrices d’antigènes (CPA) de la peau suite à la vaccination par voie intradermique chez le primate non-humain. Le ciblage des CPA a été réalisé par injection in vivo d’un anticorps monoclonal anti-HLA-DR fluorescent. L’effet sur les CPA d’un adjuvant (R-848, ligand du TLR7/8) et l’immuno-ciblage des cellules de Langerhans par une protéine de fusion vaccinale anti-VIH (anti-langérine-VIHGag) ont ainsi été évalués par imagerie in vivo, vidéomicroscopie confocale ex vivo et cytométrie en flux. Ce travail a contribué à améliorer nos connaissances immunologiques sur les effets locaux et précoces des vaccins et /ou adjuvants. / My pHD project allowed the development of in vivo imaging approaches to study the skin antigen presenting cell (APC) behavior post-intradermal vaccination in non-human primates. APC targeting was performed by in vivo injection of fluorescent anti-HLA-DR monoclonal antibody. The effect of an adjuvant (R-848, ligand of TLR7/8) on skin APC and the immunotargeting of Langerhans cells by anti-HIV vaccinal fusion protein (anti-langerin-HIVGag) were assessed by in vivo fluorescent imaging, ex vivo confocal videomicroscopy and flow cytometry. This work contributed to improve immunological knowledge on local and early events post-vaccination with or without adjuvant.

Upon encounter of an antigen, epidermis-resident Langerhans cells (LCs) become activated and present the processed antigen to T cells of the draining lymph nodes, resulting in tolerogenic or inflammatory responses. In psoriasis plaques, skin homeostasis is disrupted and replaced by an inflammatory dermatitis. Topical application of the anti-viral compound, imiquimod, induces a psoriasiform inflammatory condition, partly driven by LC production of pro-inflammatory cytokines. Differentiation of the myeloid progenitor cell line, MUTZ-3, produces MUTZ-3 derived Langerhans cells (MUTZ-LCs) which can be used as an in vitro model of LCs. This project aimed to investigate the phenotype and function of imiquimod-treated MUTZ-LCs in monolayer cultures, co-culture with T cells and inserted into a 3D skin model. LC-related surface markers (HLA-DR, CD1a, CD207, CCR7) were upregulated in MUTZ-LCs after 7 days of differentiation with 40 ng/ml GM-CSF, 10 ng/ml TGF-β and 2.5 ng/ml TNF-α. Supernatants of imiquimod-treated monolayer cultures of MUTZ-LCs showed subtle concentrations of IL-6 and TNF-α, but not IL-23. mRNA expression showed no significant upregulation of IL-6, IL-23 or TNF-α after 24 h treatment with imiquimod. The presence of MUTZ-LCs in T cell co-cultures greatly increased the production of IL-2, but did not affect expression of CD25. After 16 h exposure to imiquimod, IL-6, IL-23 and TNF-α could not be detected in culture supernatants of a 3D model consisting of fibroblasts, keratinocytes and MUTZ-LCs. The model was devoid of fibroblasts after 19 days of culture, most likely compromising the immunocompetence, as LC migration in response to activation could not be detected. Further studies could refine and optimize the imiquimod-3D skin model, which has potential as a possible substitute for animal models in psoriasis research.

Made available in DSpace on 2014-12-17T15:32:22Z (GMT). No. of bitstreams: 1 KaruzaMAP.pdf: 544780 bytes, checksum: e0fadeed7d2d1ec7568970935306d05c (MD5) Previous issue date: 2006-02-22 / Coordena??o de Aperfei?oamento de Pessoal de N?vel Superior / The Human Papillomavirus (HPV) has been strongly implicated on development of some cases of oral squamous cell carcinoma (OSCC). However, the immunological system somehow reacts against the presence of this virus. Among the cells involved on such mechanism of defense detaches the Langerhans cells (LC), which are responsible for processing and presenting antigens. The purpose of this study was to evaluate the immunohistochemical reactivity for Langerhans cells between HPV positive and HPV negative OSCC, as well as, the relation of the immunoreactivity for this cells and the histological grading of malignancy proposed by Bryne (1998) and modified by Miranda (2002). Additionally, HPV infection was evaluated in relation to sex, age, lesion localization and histological grading of malignancy. In the total, 27 cases of OSSC were evaluated, 09 of them HPV positive and 18 HPV negative. Anti S-100 antibody was utilized for the immunohistochemical labelling, followed by the counting of LCs in 5 highpower fields (400x). No statistically significant difference was verified between the variables sex, age, lesion localization, histological grading of malignancy and HPV presence in OSSC. There was neither association between the immunohistochemical labeling for LCs (S-100+) and HPV infection nor correlation between the quantity of LCs labeled and the histological grading of malignancy of OSSC. The results suggest that despite the absence of statistically significant difference, the presence of HPV in such cases of OSCC can alter the immunological system, particularly the Langerhans cells / O Papilomav?rus Humano (HPV) tem sido implicado fortemente no desenvolvimento de alguns carcinomas epiderm?ides orais (CEOs). Contudo, o sistema imunol?gico reage de alguma forma ? presen?a desse v?rus. Dentre as c?lulas envolvidas nesse mecanismo de defesa, destaca-se a c?lula de Langerhans (CL), por serem c?lulas processadoras e apresentadoras de ant?genos. O objetivo desse estudo foi avaliar a marca??o imuno-histoqu?mica das c?lulas de Langerhans entre os casos de CEOs HPV positivos e negativos, bem como a rela??o da imunomarca??o dessas c?lulas e a grada??o histol?gica de malignidade proposta por Bryne (1998) e modificada por Miranda (2002). Adicionalmente, a infec??o pelo HPV foi estudada com rela??o ao sexo, idade, localiza??o da les?o e a grada??o histol?gica de malignidade. Foram analisados 27 casos de CEOs, sendo 09 destes HPV positivos e 18 casos negativos. Para a marca??o imuno-histoqu?mica utilizou-se o anticorpo anti S-100, sendo as CLs quantificadas em 5 campos de maior aumento (400x). A an?lise estat?stica revelou n?o existir rela??o das vari?veis, sexo, idade, localiza??o da les?o e grada??o histol?gica, com a presen?a do HPV nos CEOs estudados. N?o existiu associa??o entre a marca??o imuno-histoqu?mica das CLs(S-100+) e a infec??o pelo HPV, e tamb?m n?o houve correla??o entre as CLs imunomarcadas e a grada??o histol?gica nos casos de CEOs analisados. Diante desses resultados, pode-se sugerir que mesmo n?o havendo diferen?a significativa, a presen?a do HPV nos casos de carcinoma epiderm?ide oral pode alterar o sistema imune, particularmente as c?lulas de Langerhans

La tolérance périphérique vis-à-vis de molécules potentiellement allergéniques en contact avec la peau joue un rôle essentiel pour prévenir le développement de l’eczéma allergique de contact (EAC). Au cours de ma thèse, j'ai contribué à l'identification des mécanismes et des acteurs responsables de l'induction de la tolérance par voie cutanée et à préciser le rôle respectif des sous-populations de cellules dendritiques (DC) cutanées dans la rupture de la tolérance et l'induction de lymphocytes T (LT) CD8+ initiant l'EAC. A l'aide d'un modèle murin d'induction de tolérance aux haptènes, j’ai pu montrer que les cellules de Langerhans (LC) épidermiques sont les cellules clés pour induire la tolérance cutanée et empêcher le développement d'un EAC médié par les LT CD8+. En effet, suite à l’application épicutanée d’un allergène/haptène faible, le DNTB, les LC migrent de la peau aux ganglions lymphatiques pour présenter l’antigène aux LT CD8+. Des expériences de déplétion in vivo et de transfert adoptif montrent que les LC sont responsables de la suppression de l’EAC en prévenant la différentiation des LT CD8+ spécifiques de l'allergène en cellules T cytotoxiques via deux mécanismes complémentaires: i) l’anergie/délétion des LT CD8+ et ii) l'activation de LT régulateurs Foxp3+ exprimant ICOS. Après avoir identifié des conditions d'immunisation conduisant au développement d'un EAC au DNTB, j'ai montré que la rupture de tolérance à ce type d'allergène est associée à i) à des modifications phénotypiques des LC épidermiques, ii) au recrutement rapide de monocytes inflammatoires Gr1+ dans la peau et iii) à une capacité équivalente des LC et des DC dermiques Langerin- à présenter l'allergène aux LT CD8+ dans les ganglions. Dans cette situation, les LC jouent un rôle pro-inflammatoire puisque leur déplétion réduit de manière dramatique l'induction de LT CD8+ effecteurs et l'EAC. Ces résultats indiquent que les LC jouent un rôle essentiel à la fois dans la prévention et dans l’induction de l’EAC, et que leur fonction tolérogène ou stimulatrice est vraisemblablement conditionnée par le microenvironnement cutané lors de la pénétration de l’allergène / Induction of peripheral tolerance to potentially allergenic molecules in contact with the skin is essential to prevent the development of allergic contact dermatitis (ACD). During my PhD, I contributed to the identification of the mechanisms and actors responsible for the induction of skin tolerance and clarified the respective roles of dendritic cell (DC) subsets in the breakdown of skin tolerance leading to the priming of cytotoxic CD8+ T cells and developpement of ACD. Using a mouse model of cutaneous tolerance to a model weak allergen, we show that epidermal Langerhans cells (LC) are essential to induce CD8+ T cell tolerance and prevent the development of ACD. Indeed, following the epicutaneous delivery of the weak allergen/hapten DNTB, LC were found to migrate from skin to draining lymph nodes to present the allergen to CD8+ T cells. Depletion and adoptive transfer experiments revealed that LC protect from development of ACD by preventing the priming of allergenspecific cytotoxic CD8+ T cells via two complementary mechanisms: i) anergy/deletion of allergen-specific CD8+ T cells and ii) activation of highly suppressive Foxp3+ regulatory T cells expressing ICOS. We identified DNTB skin delivery conditions that allow for CD8+ T cell priming and initiation of ACD. Breakdown of tolerance to this weak allergen was associated with i) phenotypic modifications of epidermal LC, ii) recruitment of inflammatory monocytes to the skin and iii) allergen presentation to CD8+ T cells by both LC and dermal Langerin- DC. In addition, LC are involved in tolerance breakdown as their depletion prior to skin immunization abrogated induction of CD8+ effector cells and ACD. These results demonstrate that LC are essential for both the induction of skin tolerance to weak skin allergens and for the induction of ACD, and suggest that their tolerogenic versus immuno-stimulatory function is likely dictated by signals from the skin microenvironment after penetration of the allergen

L’électroporation (EP) in vivo est utilisée comme stratégie d’amélioration de la réponse immune induite par les vaccins ADN. Cependant son effet sur les acteurs du système immunitaire inné reste méconnu. Dans l’objectif de mettre en évidence le comportement cellulaire sur le site de la vaccination, nous avons développé des approches d’imagerie par fluorescence in vivo chez le macaque. Nos résultats montrent que l’EP locale, augmente non seulement la quantité et la distribution de l’antigène vaccinal, mais induit également la mobilisation et la migration des cellules de Langerhans. De plus, l’EP cause un recrutement de leucocytes dans la peau et le tissu sous-cutané et favorise la production de cytokines pro-inflammatoires dans la peau. Ces évènements précoces, qui résultent de l’utilisation de l’EP en tant que système de délivrance des vaccins ADN, mettent en évidence le potentiel de l’EP en tant qu’adjuvant vaccinal. / In vivo electroporation (EP) is used as a strategy to improve the immune response induced by DNA vaccines. However, its local effect on the innate immune cells has not been fully described. We developed in vivo fluorescence imaging approaches to highlight the cell behavior in the site of vaccination in macaques. Our results show that the local EP not only increases the amount and the distribution of the vaccine antigen, but also induces the mobilization and migration of Langerhans cells. Furthermore, EP causes the recruitment of leukocytes into the skin and subcutaneous tissue and promotes the production of pro-inflammatory cytokines. These early events that result from the use of the EP as a delivery system for DNA vaccines, highlight its potential as a vaccine adjuvant.

Os doentes transplantados renais têm alto risco para desenvolver queratoses actínicas e câncer de pele. Para verificar o efeito quimioprofilático da acitretina estudamos a evolução de 13 doentes transplantados renais com queratoses actínicas múltiplas e história de carcinomas cutâneos submetidos a tratamento por 12 meses (20mg/dia). Fez-se a avaliação clínica e laboratorial regularmente em todo o período do estudo. Realizou-se exame histopatológico, demonstração imuno-histoquímica de sub-populações de linfócitos T (CD4, CD8), células natural killer e células de Langerhans, sua quantificação e comparação em biopsias de pele, sem lesão, de área exposta e protegida do sol antes, após seis e 12 meses de tratamento. Observou-se melhora das lesões cutâneas e ausência de aparecimento de novos tumores em 12 dos 13 pacientes. Não ocorreram alterações laboratoriais relacionadas a função renal, hepatotoxicicidade e hiperlipidemia. Não houve diferenças significativas histopatológicas e da população de linfócitos T e células natural killer da pele exposta e protegida do sol com o tratamento. Verificou-se aumento numérico de células de Langerhans epidérmicas aos 12 meses quando comparado aos da pele antes e após seis meses de tratamento (p = 0,002 e p = 0,003). Em nossa casuística o uso de acitretina em doses baixas foi útil para melhorar o aspecto cutâneo e prevenir lesões cutâneas pré-cancerosas e carcinomas. O aumento das células de Langerhans epidérmicas estaria relacionado ao efeito imunomodular da acitretina. / Renal transplant recipients have an increased incidence of actinic keratosis and skin cancer. In order to examine the chemoprophylatic effects of low-dose acitretin on skin cancer development we submitted 13 renal transplanted patients to acitretin therapy (20 mg/day) for 12 month. The patients were assessed at monthly intervals during the first 6 months and every two months until the 12th month for new skin lesions and for acitretin toxicity. Normal skin biopsies of sun exposed and sun protected area were taken for histopathological exam and submitted to immunohistochemistry technique to demonstrate CD4+ and CD8+ T lymphocytes, natural killer cells and Langerhans cells wich were counted and compared in the beginning, after 6th month and 12th month of the treatment. There was an improvement of actinic keratosis and all patients but one did not develop new skin cancer. Side-effects were well-tolerated and no significant biochemical effects were observed. Although there were no differences in the microscopic aspects of the skin and in the number of CD4+ and CD8+ T lymphocytes and natural killer cells, there was a significant increase in the number of epidermal Langerhans cells after 12 months of acitretin therapy. The data obtained permit us to conclude that low dose acitretin therapy is safe, well-tolerated and partially effective in chemoprophylaxis of skin cancer in renal transplant recipients. The increase in epidermal Langerhans cells observed may be an expression of the immunomodulatory effect of acitretin.